Approximately 80 percent of patients with bladder cancer showed a reduction in tumor size, with no reported side effects ...

Sparked by a flurry of executive orders in the first week of taking power, and evolving at dizzying pace, the new US administration has taken a wrecking ball to health-related services and research ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

Today, if we are the lawabiding kind, we often have to wait at signals even if there’s no traffic flow from the other side ...

North America urinalysis market is projected to grow by 6.3% annually in the forecast period and reach $1,973.2 million by 2031, driven by the growing geriatric population, the prevalence of ...

Global urinalysis market will reach $5,348.8 million by 2031, growing by 6.6% annually over 2021-2031, driven by the growing geriatric population, the prevalence of age-related diseases, the growing ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

TD Cowen increased its price target on Gilead Sciences (NASDAQ:GILD) shares to $100 from the previous $95, while maintaining a Buy rating on the stock. The biotech giant, currently trading near its 52 ...

Oppenheimer reiterated its Outperform rating and $115.00 price target for Gilead Sciences (NASDAQ:GILD) stock, following a strong fourth-quarter performance that surpassed consensus estimates. Gilead ...

First, liver parenchyma was divided into 3 main sectors according to the distribution of hepatic vein branches: left lobe (segments II, III and IV), right anterior (segments V and VIII) and right ...